Is ERS or JNJ a better dividend investment in 2026?

ERS currently yields 28.57% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: ERS offers higher current income.

What is the dividend yield difference between ERS and JNJ?

ERS has a forward dividend yield of 28.57% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 25.21 percentage points.

Home › Compare › ERS vs JNJ

ERS vs JNJ: Dividend Comparison 2026

ERS yields 28.57% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ERS wins by $1105718.43M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ERS

● Live price

28.57%

Share price

$7.00

Annual div

$2.00

5Y div CAGR

73.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1105718.45M

Annual income

$1,076,252,382,049.65

Full ERS calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — ERS vs JNJ

📍 ERS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ERS	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ERS + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ERS pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ERS

Annual income on $10K today (after 15% tax)

$2,428.57/yr

After 10yr DRIP, annual income (after tax)

$914,814,524,742.20/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, ERS beats the other by $914,814,524,038.59/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ERS + JNJ for your $10,000?

ERS: 50%JNJ: 50%

100% JNJ50/50100% ERS

Portfolio after 10yr

$552859.24M

Annual income

$538,126,191,438.72/yr

Blended yield

97.34%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ERS

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ERS buys

JNJ buys

No recent congressional trades found for ERS or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricERSJNJ

Forward yield	28.57% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	73.8% ✓	5.8%
Portfolio after 10y	$1105718.45M ✓	$20.0K
Annual income after 10y	$1,076,252,382,049.65 ✓	$827.78
Total dividends collected	$1103708.65M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ERS vs JNJ ($10,000, DRIP)

Year	ERS Portfolio	ERS Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$15,666	$4,965.71	$10,676	$355.77	+$5.0K → ERS
2	$29,398	$12,635.66	$11,407	$389.39	+$18.0K → ERS
3	$69,971	$38,515.11	$12,198	$426.53	+$57.8K → ERS
4	$223,770	$148,900.93	$13,056	$467.62	+$210.7K → ERS
5	$1,012,910	$773,476.74	$13,987	$513.12	+$998.9K → ERS
6	$6,770,808	$5,686,993.84	$14,998	$563.56	+$6.76M → ERS
7	$68,992,096	$61,747,331.70	$16,098	$619.52	+$68.98M → ERS
8	$1,095,803,032	$1,021,981,489.45	$17,295	$681.69	+$1095.79M → ERS
9	$27,538,383,781	$26,365,874,536.61	$18,599	$750.82	+$27538.37M → ERS
10	$1,105,718,452,696	$1,076,252,382,049.65	$20,022	$827.78	+$1105718.43M → ERS

ERS vs JNJ: Complete Analysis 2026

ERS — Stock

ERS is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in ERS shares.

Full ERS Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this ERS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ERS vs SCHD ERS vs JEPI ERS vs O ERS vs KO ERS vs MAIN ERS vs ABBV ERS vs MRK ERS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.